Hansa Biopharma competitive analysis

Loading summary...

Explore patent oppositions filed by Hansa Biopharma against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 23, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

Compositions And Methods For Increasing Or Enhancing Transduction Of Gene Therapy Vectors And For Removing Or Reducing ImmunoglobulinsGENETHONJul 12, 2023
New Streptococcal ProteasesGENOVISDec 23, 2021

Latest publications and patents of Hansa Biopharma New

Explore the latest publications and patents granted to Hansa Biopharma, showcasing their recent innovations and technological advancements.

Latest PTAB cases involving Hansa Biopharma

Discover the latest PTAB cases involving Hansa Biopharma, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Hansa Biopharma with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
HANSA BIOPHARMA2 - - -
GENETHON - 19 - -
GENOVIS11 - -
INSERM INSTITUT NATIONAL DE LA SANT ET DE LA RECHERCHE MDICALE - 36 - -